Hetgloby 5% Injection – Human Normal Immunoglobulin | Product Details, Benefits

Hetgloby 5% Injection contains Human Normal Immunoglobulin and is used under medical supervision for selected immune deficiencies and immune-related conditions. Cordium Pharmaceuticals Pvt Ltd provides product information and enquiries for pharmaceutical supply, subject to availability and applicable export regulations.

Product Description

Hetgloby 5% Injection is an immunoglobulin preparation containing antibodies (immunoglobulins) that help the body defend itself against infections. Human normal immunoglobulin is generally derived from screened human plasma and processed using manufacturing steps designed to reduce the risk of transmitting infections.

The 5% strength generally corresponds to 50 mg of immunoglobulin per mL. Confirm the exact composition, presentation, manufacturer details and approved route of administration on the product label before use.

Human Normal Immunoglobulin 5% may be prescribed for patients who have insufficient antibodies or certain immune-system disorders. Its specific indications depend on the approved product information and the treating specialist’s assessment.

Benefits and Medical Uses

The potential benefits of Human Normal Immunoglobulin therapy depend on the patient's diagnosis and treatment plan.

Antibody replacement: Helps provide antibodies to patients with certain primary or secondary immunodeficiency conditions.

Immune-system regulation: Certain immunoglobulin preparations are used to modify abnormal immune responses in selected medical conditions.

Support for specialist treatment: May form part of a clinician-directed treatment plan for approved indications.

Individualised care: Treatment and monitoring are tailored to the patient's condition, clinical response and risk factors.

Hetgloby 5% Injection is not a general-purpose immunity booster. It should only be used when prescribed for an appropriate medical indication.

Dosage and Administration

Hetgloby 5% Injection should be administered by qualified healthcare professionals according to the product's approved prescribing information.

The dose, infusion rate and treatment frequency depend on the patient's body weight, diagnosis, clinical condition and response to therapy. Patients should not self-administer this medicine or change their treatment schedule without medical advice.

Possible Side Effects

Human Normal Immunoglobulin may cause side effects, although not every patient experiences them.

Common or recognised reactions may include:

Headache or dizziness

Fever or chills

Nausea or vomiting

Fatigue

Muscle, joint or back pain

Infusion-related discomfort

Serious but less common risks can include severe allergic reactions, blood clots, kidney problems, red blood cell destruction and inflammation of the membranes surrounding the brain.

Seek urgent medical attention for difficulty breathing, chest pain, sudden weakness, severe headache with neck stiffness, or swelling and pain in a limb. Tell your doctor about kidney disease, previous blood clots, allergies, pregnancy, and all medicines you take before treatment.

Storage and Handling

Follow the storage conditions printed on the approved product packaging and accompanying leaflet. Many 5% immunoglobulin products require refrigerated storage at 2°C–8°C and must not be frozen; however, the exact requirements for Hetgloby should be verified against its product-specific label. Maintain appropriate temperature controls during storage and transportation.

Frequently Asked Questions

1. What is Hetgloby 5% Injection used for?

It contains Human Normal Immunoglobulin and may be prescribed for selected antibody deficiencies and other approved immune-related conditions.

2. What is the composition of Hetgloby 5% Injection?

The stated active ingredient is Human Normal Immunoglobulin at 5% strength. Check the product label for the exact composition and pack details.

3. Can Hetgloby 5% Injection be used without a prescription?

No. It requires medical assessment and administration under appropriate professional supervision.

4. What side effects can occur?

Headache, fever, chills, nausea and infusion-related reactions may occur. Serious symptoms require immediate medical attention.

5. How can buyers enquire about Hetgloby 5% Injection from India?

Hospitals, authorised pharmaceutical distributors and eligible institutional buyers can contact Cordium Pharmaceuticals Pvt Ltd to enquire about product availability, quotation, export documentation and shipping requirements. Supply is subject to applicable laws and destination-country import regulations.

Contact Cordium Pharmaceuticals Pvt Ltd

For Hetgloby 5% Injection product enquiries, pharmaceutical distribution and export supply from India, contact Cordium Pharmaceuticals Pvt Ltd for current availability, commercial terms and documentation requirements.

Medical disclaimer: This page provides general product information and is not a substitute for professional medical advice .